$HRTX Cashflow Statement | Understand Stock

$HRTX

$0.30 -$0.00 (0.69%) Close

$HRTX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense
Depreciation and amortization
Amortization of debt discount
Amortization of debt issuance costs
Accretion of discount on short-term investments
Realized gain on available-for-sale investments
Retirement and impairment of property and equipment
(Gain)/Loss on disposal of property and equipment
Loss on extinguishment of debt
Change in operating assets and liabilities:
Accounts receivable
Inventory
Prepaid expenses and other assets
Accounts payable
Accrued clinical and manufacturing liabilities
Accrued payroll and employee liabilities
Other accrued liabilities
Net cash used in operating activities
Investing activities:
Purchases of short-term investments
Maturities and sales of short-term investments
Purchases of property and equipment
Proceeds from the sale of property and equipment
Net cash provided by investing activities
Financing activities:
Net proceeds from the sale of common stock
Net proceeds from notes financing
Proceeds from sale of Series A Convertible Preferred Stock
Cash paid for convertible notes extinguishment
Cash paid for notes extinguishment
Net proceeds from convertible note issuance
Net proceeds from notes issuance
Proceeds from warrant exercises
Proceeds from purchases under the Employee Stock Purchase Plan
Proceeds from stock issued under the equity incentive plan
Receipts (payments) for stock issued under the equity incentive plan
Net cash provided by financing activities

Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year
Supplemental disclosure of cash flow information:
Interest paid

Comments